Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Palonosetron" patented technology

This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It is also used to prevent nausea and vomiting after surgery.

Palonosetron formulation

The present invention provides solid oral formulations of palonosetron or salts thereof.
Owner:TEVA PHARM USA INC

Palonosetron for the treatment or prevention of nausea and vomiting

ActiveUS20200345632A1Rapid long-term ameliorationFast systemic absorptionOrganic active ingredientsDigestive systemPalonosetronPharmaceutical medicine
The invention relates to a method for treating or preventing nausea and vomiting. The method comprises administering an eye drop composition comprising palonosetron or a pharmaceutically acceptable salt thereof to the eye of the subject. The ocular administration results in fast systemic absorption, improved bioavailability compared to oral route and extended elimination time.
Owner:ORION CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products